ID: ALA4084785

Max Phase: Preclinical

Molecular Formula: C38H47N7O4S

Molecular Weight: 697.91

Molecule Type: Small molecule

Representations

Canonical SMILES:  CC(C)C[C@H](NC(=O)[C@H](CCc1ccccc1)NC(=O)CCc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)c1nc2ccccc2s1

Standard InChI:  InChI=1S/C38H47N7O4S/c1-25(2)24-31(36(49)43-29(17-11-23-41-38(39)40)34(47)37-45-28-16-9-10-18-32(28)50-37)44-35(48)30(21-19-26-12-5-3-6-13-26)42-33(46)22-20-27-14-7-4-8-15-27/h3-10,12-16,18,25,29-31H,11,17,19-24H2,1-2H3,(H,42,46)(H,43,49)(H,44,48)(H4,39,40,41)/t29-,30-,31-/m0/s1

Standard InChI Key:  FUTBVVSROFKXMI-CHQNGUEUSA-N

Molecule Features

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type: Small molecule

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Properties

Molecular Weight: 697.91

Molecular Weight (Monoisotopic): 697.3410

AlogP: 4.51

#Rotatable Bonds: 19

Polar Surface Area: 179.16

Molecular Species: BASE

HBA: 7

HBD: 6

#RO5 Violations: 2

HBA (Lipinski): 11

HBD (Lipinski): 7

#RO5 Violations (Lipinski): 3

CX Acidic pKa: 11.95

CX Basic pKa: 11.62

CX LogP: 4.74

CX LogD: 2.75

Aromatic Rings: 4

Heavy Atoms: 50

QED Weighted: 0.04

Np Likeness Score: -0.34

References

1. St-Georges C, Désilets A, Béliveau F, Ghinet M, Dion SP, Colombo É, Boudreault PL, Najmanovich RJ, Leduc R, Marsault É..  (2017)  Modulating the selectivity of matriptase-2 inhibitors with unnatural amino acids.,  129  [PMID:28219045] [10.1016/j.ejmech.2017.02.006]

Source

Source(1):

• Scientific Literature